nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepyramine—CYP2D6—Bicalutamide—prostate cancer	0.253	0.504	CbGbCtD
Mepyramine—CYP2D6—Abiraterone—prostate cancer	0.21	0.418	CbGbCtD
Mepyramine—CYP2D6—Doxorubicin—prostate cancer	0.0388	0.0773	CbGbCtD
Mepyramine—Rosiglitazone—ACSL4—prostate cancer	0.0141	0.445	CrCbGaD
Mepyramine—CYP2D6—urine—prostate cancer	0.0116	0.126	CbGeAlD
Mepyramine—SLC22A4—prostate gland—prostate cancer	0.00976	0.106	CbGeAlD
Mepyramine—SLC22A4—seminal vesicle—prostate cancer	0.00826	0.0897	CbGeAlD
Mepyramine—SLC22A4—renal system—prostate cancer	0.00665	0.0723	CbGeAlD
Mepyramine—SLC22A5—prostate gland—prostate cancer	0.00646	0.0702	CbGeAlD
Mepyramine—HRH1—prostate gland—prostate cancer	0.00548	0.0595	CbGeAlD
Mepyramine—SLC22A5—seminal vesicle—prostate cancer	0.00546	0.0594	CbGeAlD
Mepyramine—SLC22A4—bone marrow—prostate cancer	0.00503	0.0547	CbGeAlD
Mepyramine—SLC22A5—renal system—prostate cancer	0.0044	0.0479	CbGeAlD
Mepyramine—SLC22A5—urethra—prostate cancer	0.00433	0.047	CbGeAlD
Mepyramine—HRH1—epithelium—prostate cancer	0.00403	0.0438	CbGeAlD
Mepyramine—HRH1—urethra—prostate cancer	0.00367	0.0399	CbGeAlD
Mepyramine—SLC22A4—lymph node—prostate cancer	0.00312	0.0339	CbGeAlD
Mepyramine—SLC22A5—testis—prostate cancer	0.00285	0.0309	CbGeAlD
Mepyramine—CYP2D6—renal system—prostate cancer	0.00284	0.0309	CbGeAlD
Mepyramine—HRH1—testis—prostate cancer	0.00241	0.0262	CbGeAlD
Mepyramine—Rosiglitazone—CYP2A6—prostate cancer	0.00237	0.0749	CrCbGaD
Mepyramine—SLC22A5—lymph node—prostate cancer	0.00206	0.0224	CbGeAlD
Mepyramine—CYP2D6—testis—prostate cancer	0.00184	0.02	CbGeAlD
Mepyramine—HRH1—lymph node—prostate cancer	0.00175	0.019	CbGeAlD
Mepyramine—Rosiglitazone—CYP2C19—prostate cancer	0.00166	0.0527	CrCbGaD
Mepyramine—Chlorphenamine—SLC22A1—prostate cancer	0.00162	0.0512	CrCbGaD
Mepyramine—Diltiazem—CYP3A5—prostate cancer	0.00156	0.0495	CrCbGaD
Mepyramine—Chlorphenamine—CYP3A5—prostate cancer	0.00131	0.0413	CrCbGaD
Mepyramine—Diltiazem—CYP2C19—prostate cancer	0.00106	0.0337	CrCbGaD
Mepyramine—Carbinoxamine—CYP2E1—prostate cancer	0.00106	0.0334	CrCbGaD
Mepyramine—Carbinoxamine—CYP2C19—prostate cancer	0.00105	0.0331	CrCbGaD
Mepyramine—Brompheniramine—CYP2E1—prostate cancer	0.000914	0.0289	CrCbGaD
Mepyramine—Brompheniramine—CYP2C19—prostate cancer	0.000905	0.0286	CrCbGaD
Mepyramine—Diltiazem—CYP3A4—prostate cancer	0.000677	0.0214	CrCbGaD
Mepyramine—Carbinoxamine—CYP3A4—prostate cancer	0.000665	0.021	CrCbGaD
Mepyramine—Methotrimeprazine—CYP2E1—prostate cancer	0.000606	0.0192	CrCbGaD
Mepyramine—Orphenadrine—CYP2E1—prostate cancer	0.000576	0.0182	CrCbGaD
Mepyramine—Brompheniramine—CYP3A4—prostate cancer	0.000576	0.0182	CrCbGaD
Mepyramine—Chlorphenamine—CYP3A4—prostate cancer	0.000565	0.0179	CrCbGaD
Mepyramine—Orphenadrine—CYP3A4—prostate cancer	0.000363	0.0115	CrCbGaD
Mepyramine—HRH1—Signaling Pathways—PLXNB1—prostate cancer	0.000172	0.000459	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—LPAR1—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GRP—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PLCB2—prostate cancer	0.000167	0.000447	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—GNG5—prostate cancer	0.000167	0.000446	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRPR—prostate cancer	0.000166	0.000442	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000164	0.000438	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CX3CL1—prostate cancer	0.000164	0.000438	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TST—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ADI1—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PSAT1—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CBR1—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GRHL1—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CSAD—prostate cancer	0.000161	0.000431	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL17RD—prostate cancer	0.00016	0.000427	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PDE4D—prostate cancer	0.00016	0.000426	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GNG5—prostate cancer	0.000152	0.000405	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CKMT2—prostate cancer	0.00015	0.0004	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—UGT2B17—prostate cancer	0.00015	0.0004	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GRHPR—prostate cancer	0.00015	0.0004	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—UGT2B15—prostate cancer	0.00015	0.0004	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PTHLH—prostate cancer	0.000146	0.000389	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—JUP—prostate cancer	0.000143	0.000381	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—WNT4—prostate cancer	0.000143	0.000381	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PGAM2—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MBTPS1—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AOX1—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SULT2B1—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—RFK—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NAGLU—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTM3—prostate cancer	0.000141	0.000376	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ANXA1—prostate cancer	0.000137	0.000366	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MC2R—prostate cancer	0.000136	0.000363	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RALBP1—prostate cancer	0.000136	0.000363	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—DEGS1—prostate cancer	0.000134	0.000357	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP3A43—prostate cancer	0.000134	0.000357	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SRD5A2—prostate cancer	0.000134	0.000357	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AMACR—prostate cancer	0.000134	0.000357	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NAT1—prostate cancer	0.000134	0.000357	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PTHLH—prostate cancer	0.000132	0.000353	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PRKACB—prostate cancer	0.00013	0.000346	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CALCA—prostate cancer	0.000128	0.000342	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HSD17B1—prostate cancer	0.000128	0.00034	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	0.000126	0.000337	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	0.000125	0.000334	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ANXA1—prostate cancer	0.000124	0.000332	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PENK—prostate cancer	0.000121	0.000324	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000121	0.000322	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000119	0.000318	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CALCA—prostate cancer	0.000117	0.000311	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GHR—prostate cancer	0.000116	0.000309	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000116	0.000308	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000114	0.000305	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	0.000114	0.000304	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—B4GALT4—prostate cancer	0.000114	0.000303	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HPGD—prostate cancer	0.000114	0.000303	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000113	0.0003	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NRP1—prostate cancer	0.000111	0.000296	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	0.000108	0.000287	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	0.000107	0.000285	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	0.000105	0.00028	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MTAP—prostate cancer	0.000104	0.000278	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP7B1—prostate cancer	0.000104	0.000278	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	0.000104	0.000277	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000103	0.000276	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VIP—prostate cancer	0.000103	0.000275	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GNRH1—prostate cancer	0.000103	0.000275	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	0.000102	0.000271	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SRD5A1—prostate cancer	0.000101	0.00027	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SULT1E1—prostate cancer	0.000101	0.00027	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LPAR1—prostate cancer	9.99e-05	0.000267	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRP—prostate cancer	9.99e-05	0.000267	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PLCB2—prostate cancer	9.89e-05	0.000264	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LRP2—prostate cancer	9.89e-05	0.000264	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	9.77e-05	0.00026	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	9.7e-05	0.000259	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—P4HB—prostate cancer	9.7e-05	0.000259	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ACSL4—prostate cancer	9.67e-05	0.000258	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HSD17B3—prostate cancer	9.67e-05	0.000258	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—VAV3—prostate cancer	9.52e-05	0.000254	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	9.52e-05	0.000254	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PDE4D—prostate cancer	9.44e-05	0.000252	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRB7—prostate cancer	9.44e-05	0.000252	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PHGDH—prostate cancer	9.27e-05	0.000247	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ARG2—prostate cancer	9.27e-05	0.000247	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—UMPS—prostate cancer	9.27e-05	0.000247	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	9.24e-05	0.000246	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	9.2e-05	0.000245	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	9.19e-05	0.000245	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	9.16e-05	0.000244	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—LDHB—prostate cancer	9.1e-05	0.000243	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GNG5—prostate cancer	8.98e-05	0.000239	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP3A5—prostate cancer	8.93e-05	0.000238	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA3—prostate cancer	8.62e-05	0.00023	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TCN2—prostate cancer	8.62e-05	0.00023	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PDHA1—prostate cancer	8.62e-05	0.00023	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—UCP3—prostate cancer	8.62e-05	0.00023	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HSD3B1—prostate cancer	8.23e-05	0.000219	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC22A3—prostate cancer	8.23e-05	0.000219	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TBXAS1—prostate cancer	7.89e-05	0.00021	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA4—prostate cancer	7.89e-05	0.00021	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PTHLH—prostate cancer	7.82e-05	0.000209	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	7.82e-05	0.000209	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	7.69e-05	0.000205	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA2—prostate cancer	7.68e-05	0.000205	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PRKACB—prostate cancer	7.65e-05	0.000204	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ABCG5—prostate cancer	7.59e-05	0.000202	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SULT1A1—prostate cancer	7.59e-05	0.000202	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—THBS1—prostate cancer	7.46e-05	0.000199	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	7.46e-05	0.000199	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA1—prostate cancer	7.41e-05	0.000198	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ANXA1—prostate cancer	7.35e-05	0.000196	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HSD3B2—prostate cancer	7.33e-05	0.000196	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTO1—prostate cancer	7.33e-05	0.000196	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NAT2—prostate cancer	7.33e-05	0.000196	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	7.22e-05	0.000192	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	7.05e-05	0.000188	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PLCB2—prostate cancer	7.03e-05	0.000187	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—LRP2—prostate cancer	7.03e-05	0.000187	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.03e-05	0.000187	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGFR4—prostate cancer	6.97e-05	0.000186	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PARP1—prostate cancer	6.97e-05	0.000186	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—P4HB—prostate cancer	6.89e-05	0.000184	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CALCA—prostate cancer	6.88e-05	0.000184	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL12—prostate cancer	6.72e-05	0.000179	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC22A1—prostate cancer	6.71e-05	0.000179	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.53e-05	0.000174	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MED12—prostate cancer	6.43e-05	0.000171	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	6.41e-05	0.000171	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GNG5—prostate cancer	6.38e-05	0.00017	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CASP9—prostate cancer	6.33e-05	0.000169	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	6.2e-05	0.000165	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA3—prostate cancer	6.14e-05	0.000164	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	6.14e-05	0.000164	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NGFR—prostate cancer	6.14e-05	0.000164	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	6.06e-05	0.000162	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HPGDS—prostate cancer	5.86e-05	0.000156	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF10—prostate cancer	5.83e-05	0.000156	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP2C19—prostate cancer	5.82e-05	0.000155	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRB2—prostate cancer	5.77e-05	0.000154	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	5.69e-05	0.000152	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ACHE—prostate cancer	5.68e-05	0.000152	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTT1—prostate cancer	5.68e-05	0.000152	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	5.67e-05	0.000151	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	5.63e-05	0.00015	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VAV3—prostate cancer	5.63e-05	0.00015	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.62e-05	0.00015	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	5.55e-05	0.000148	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.47e-05	0.000146	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ITPR1—prostate cancer	5.46e-05	0.000146	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PRKACB—prostate cancer	5.44e-05	0.000145	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	5.4e-05	0.000144	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.38e-05	0.000144	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF1R—prostate cancer	5.22e-05	0.000139	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	5.19e-05	0.000139	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—JAK2—prostate cancer	5.17e-05	0.000138	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA2—prostate cancer	5.13e-05	0.000137	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LPL—prostate cancer	5e-05	0.000133	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—IL2—prostate cancer	4.96e-05	0.000132	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	4.96e-05	0.000132	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	4.91e-05	0.000131	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.89e-05	0.00013	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ITGB3—prostate cancer	4.83e-05	0.000129	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.78e-05	0.000127	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NQO1—prostate cancer	4.72e-05	0.000126	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	4.72e-05	0.000126	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ERBB3—prostate cancer	4.69e-05	0.000125	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGFR2—prostate cancer	4.68e-05	0.000125	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TH—prostate cancer	4.66e-05	0.000124	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.61e-05	0.000123	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.53e-05	0.000121	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—IL2—prostate cancer	4.51e-05	0.00012	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TERT—prostate cancer	4.49e-05	0.00012	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GGT1—prostate cancer	4.39e-05	0.000117	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA1—prostate cancer	4.32e-05	0.000115	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIF1A—prostate cancer	4.3e-05	0.000115	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.26e-05	0.000114	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LEP—prostate cancer	4.19e-05	0.000112	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CAV1—prostate cancer	4.15e-05	0.000111	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—RXRA—prostate cancer	4.11e-05	0.00011	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—KDR—prostate cancer	4.11e-05	0.00011	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ESR1—prostate cancer	4e-05	0.000107	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—COMT—prostate cancer	3.96e-05	0.000106	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.94e-05	0.000105	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—BAD—prostate cancer	3.91e-05	0.000104	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.88e-05	0.000103	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—APC—prostate cancer	3.78e-05	0.000101	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	3.78e-05	0.000101	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IRS1—prostate cancer	3.74e-05	9.98e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EGF—prostate cancer	3.74e-05	9.98e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TYMS—prostate cancer	3.66e-05	9.77e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GSK3B—prostate cancer	3.63e-05	9.68e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.62e-05	9.66e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—INS—prostate cancer	3.58e-05	9.55e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—LPL—prostate cancer	3.55e-05	9.48e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CREBBP—prostate cancer	3.51e-05	9.36e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF1—prostate cancer	3.46e-05	9.24e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—EGFR—prostate cancer	3.45e-05	9.19e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.43e-05	9.15e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.4e-05	9.08e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	3.35e-05	8.93e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.33e-05	8.87e-05	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.29e-05	8.79e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.29e-05	8.78e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.26e-05	8.69e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.2e-05	8.53e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF2—prostate cancer	3.19e-05	8.5e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOS3—prostate cancer	3.14e-05	8.38e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PPARA—prostate cancer	3.14e-05	8.37e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—JAK2—prostate cancer	3.05e-05	8.14e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	2.99e-05	7.98e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MDM2—prostate cancer	2.98e-05	7.95e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CAV1—prostate cancer	2.95e-05	7.87e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ERBB2—prostate cancer	2.94e-05	7.84e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	2.9e-05	7.73e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL8—prostate cancer	2.79e-05	7.43e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.72e-05	7.26e-05	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.69e-05	7.18e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.69e-05	7.17e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CASP3—prostate cancer	2.67e-05	7.11e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL2—prostate cancer	2.66e-05	7.1e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—IL6—prostate cancer	2.65e-05	7.07e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CCND1—prostate cancer	2.6e-05	6.92e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.57e-05	6.86e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—INS—prostate cancer	2.55e-05	6.79e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MMP9—prostate cancer	2.52e-05	6.72e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	2.51e-05	6.7e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PTEN—prostate cancer	2.51e-05	6.68e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.49e-05	6.65e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.44e-05	6.52e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EP300—prostate cancer	2.39e-05	6.37e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.36e-05	6.3e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SRC—prostate cancer	2.32e-05	6.2e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.26e-05	6.04e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—STAT3—prostate cancer	2.24e-05	5.98e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NOS3—prostate cancer	2.23e-05	5.95e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MYC—prostate cancer	2.08e-05	5.55e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.08e-05	5.54e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.06e-05	5.49e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.04e-05	5.44e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.04e-05	5.43e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.92e-05	5.13e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PTEN—prostate cancer	1.78e-05	4.75e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.77e-05	4.71e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TP53—prostate cancer	1.71e-05	4.56e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—EP300—prostate cancer	1.7e-05	4.53e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL6—prostate cancer	1.57e-05	4.17e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.44e-05	3.85e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.26e-05	3.35e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AKT1—prostate cancer	1.03e-05	2.74e-05	CbGpPWpGaD
